Lowers the Risk of Head and Neck Cancers
Head and neck cancers typically originate in the squamous cells, which line the mucosal surfaces in the mouth, throat, and nose. The primary causes of cancer in this region are often attributed to excessive alcohol consumption and tobacco use. However, research indicates that aspirin has the potential to act as a chemopreventive agent, reducing the risk of head and neck cancers by around 25%.
Aspirin Provides Relief for Liver Cancer
When it comes to liver cancer, aspirin has shown promising results in providing relief. A recent study has revealed that individuals who regularly take aspirin for a year can significantly reduce the risk of complications associated with liver cancer. Specifically, it has been found to effectively decrease the incidence of hepatocellular carcinoma (HCC) and even lower the mortality rate from chronic liver disease by an impressive 57%.
However, it is important to note that taking aspirin solely for the purpose of protecting oneself from liver cancer is not recommended. Ongoing research is being conducted to further understand the impact of aspirin on individuals who already have liver cancer. By gaining more insights into this area, medical professionals hope to uncover additional ways in which aspirin can contribute to the treatment and management of liver cancer.